JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
L. Ladislau +21 more
semanticscholar +1 more source
Early detection and intervention in dermatomyositis: current evidence and clinical implications. [PDF]
Treasure K, Chugh R, Abbas H, Patel A.
europepmc +1 more source
EBV-positive diffuse large B-cell lymphoma with central nervous system involvement in Anti-Mi-2-positive dermatomyositis. [PDF]
Kachi S +11 more
europepmc +1 more source
Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositis. [PDF]
Nelson MC +7 more
europepmc +1 more source
Management and Prognosis of Anti-MDA5 Dermatomyositis: Insights from a National Multicenter Cohort. [PDF]
Mogyoróssy S +20 more
europepmc +1 more source
Anti-NXP2 antibody-positive dermatomyositis presenting as systemic capillary leak syndrome with cutaneous and gastrointestinal ulcers. [PDF]
Nakamura R +6 more
europepmc +1 more source
Dermatomyositis Mimicking Statin-Induced Myopathy in A 62-Year-Old Woman. [PDF]
Pastrana-Echevarria I +3 more
europepmc +1 more source
Dupilumab therapy facilitates the histopathologic diagnosis of dermatomyositis in a patient with intercurrent severe atopic dermatitis and dermatomyositis. [PDF]
Wilson C +4 more
europepmc +1 more source
Near resolution of cutaneous lesions in long standing refractory dermatomyositis with deucravacitinib: A case report and literature review. [PDF]
Alihosseini C +3 more
europepmc +1 more source

